Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

REGN

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:REGN
DateTimeSourceHeadlineSymbolCompany
14/02/201922:37Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:REGNRegeneron Pharmaceuticals Inc
14/02/201904:09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REGNRegeneron Pharmaceuticals Inc
13/02/201900:30GlobeNewswire Inc.New Research Coverage Highlights Overstock, Regeneron Pharmaceuticals, Molecular Templates, The Ensign Group, Limoneira, and ...NASDAQ:REGNRegeneron Pharmaceuticals Inc
12/02/201907:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REGNRegeneron Pharmaceuticals Inc
11/02/201923:57Dow Jones NewsRegeneron, Sanofi to Offer Praluent at Reduced U.S. List PriceNASDAQ:REGNRegeneron Pharmaceuticals Inc
11/02/201923:00PR Newswire (US)Sanofi and Regeneron offer Praluent® (alirocumab) at a new reduced U.S. list priceNASDAQ:REGNRegeneron Pharmaceuticals Inc
11/02/201922:59PR Newswire (US)Regeneron and Sanofi Offer Praluent® (alirocumab) at a New Reduced U.S. List PriceNASDAQ:REGNRegeneron Pharmaceuticals Inc
10/02/201908:30PR Newswire (US)One-Year Results from Positive Phase 3 EYLEA Trial in Diabetic Retinopathy Presented at Angiogenesis SymposiumNASDAQ:REGNRegeneron Pharmaceuticals Inc
08/02/201908:16Edgar (US Regulatory)Annual Report (10-k)NASDAQ:REGNRegeneron Pharmaceuticals Inc
07/02/201909:34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REGNRegeneron Pharmaceuticals Inc
06/02/201923:49Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REGNRegeneron Pharmaceuticals Inc
06/02/201923:26Dow Jones NewsRegeneron Pharmaceuticals 4Q Profit RisesNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/02/201922:30PR Newswire (US)Regeneron Reports Fourth Quarter and Full Year 2018 Financial and Operating ResultsNASDAQ:REGNRegeneron Pharmaceuticals Inc
04/02/201916:59PR Newswire (US)CHMP Recommends Approval of Praluent® (alirocumab) Injection to Reduce Cardiovascular Risk in People with Established Athero...NASDAQ:REGNRegeneron Pharmaceuticals Inc
24/01/201904:01PR Newswire (US)Forty of the Nation's Most Brilliant Young Scientists Named Finalists in Regeneron Science Talent Search 2019NASDAQ:REGNRegeneron Pharmaceuticals Inc
19/01/201909:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
19/01/201908:01PR Newswire (US)Regeneron to Report Fourth Quarter and Full Year 2018 Financial and Operating Results and Host Conference Call and Webcast on...NASDAQ:REGNRegeneron Pharmaceuticals Inc
12/01/201908:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
07/01/201923:15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REGNRegeneron Pharmaceuticals Inc
07/01/201923:00PR Newswire (US)Regeneron Provides Update on Commercial and Pipeline Progress at J.P. Morgan Healthcare ConferenceNASDAQ:REGNRegeneron Pharmaceuticals Inc
07/01/201919:14Dow Jones NewsSanofi, Regeneron Restructure Immuno-Oncology AgreementNASDAQ:REGNRegeneron Pharmaceuticals Inc
07/01/201918:30PR Newswire (US)Regeneron and Sanofi Restructure Immuno-Oncology Collaboration for Discovery and Development ProgramsNASDAQ:REGNRegeneron Pharmaceuticals Inc
05/01/201908:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
05/01/201908:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
05/01/201908:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
05/01/201908:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
05/01/201908:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
05/01/201908:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
05/01/201908:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
05/01/201908:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:REGN

Your Recent History

Delayed Upgrade Clock